Covered recipient · General Payments record
MICHELLE M NASH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,125.04
- Reported across 116 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $617.23 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $227.85 | 11 |
| GlaxoSmithKline, LLC. | $108.62 | 5 |
| Amgen Inc. | $72.02 | 3 |
| E.R. Squibb & Sons, L.L.C. | $69.75 | 3 |
| UCB, Inc. | $35.75 | 1 |
| Sandoz Inc. | $28.48 | 1 |
| Janssen Biotech, Inc. | $24.49 | 1 |
| Fresenius Kabi USA, LLC | $20.08 | 1 |
| Lilly USA, LLC | $15.94 | 1 |
| PFIZER INC. | $14.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.53 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720609 | CMS |
| ABBVIE INC. | $2.26 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720611 | CMS |
| ABBVIE INC. | $18.40 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720613 | CMS |
| ABBVIE INC. | $29.10 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720615 | CMS |
| ABBVIE INC. | $20.46 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720617 | CMS |
| ABBVIE INC. | $25.23 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720619 | CMS |
| ABBVIE INC. | $12.23 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720621 | CMS |
| ABBVIE INC. | $24.04 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720623 | CMS |
| ABBVIE INC. | $23.89 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720625 | CMS |
| ABBVIE INC. | $26.75 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720627 | CMS |
| ABBVIE INC. | $21.96 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720629 | CMS |
| Amgen Inc. | $24.92 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117336900 | CMS |
| Amgen Inc. | $21.67 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117336898 | CMS |
| Amgen Inc. | $25.43 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117336902 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.16 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101468048 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.10 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101468060 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.49 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101468151 | CMS |
| Fresenius Kabi USA, LLC | $20.08 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146943180 | CMS |
| GlaxoSmithKline, LLC. | $22.73 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116614884 | CMS |
| GlaxoSmithKline, LLC. | $23.15 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116245792 | CMS |
| GlaxoSmithKline, LLC. | $22.11 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116126194 | CMS |
| GlaxoSmithKline, LLC. | $21.47 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116036634 | CMS |
| GlaxoSmithKline, LLC. | $19.16 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116249112 | CMS |
| Janssen Biotech, Inc. | $24.49 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078778391 | CMS |
| Lilly USA, LLC | $15.94 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135836545 | CMS |
| PFIZER INC. | $14.25 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131753962 | CMS |
| Sandoz Inc. | $28.48 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089364165 | CMS |
| UCB, Inc. | $35.75 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143147330 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.